Skip to main content
Top
Published in: Journal of Urban Health 6/2009

01-11-2009

Temporal Trends in Spatial Access to Pharmacies that Sell Over-the-Counter Syringes in New York City Health Districts: Relationship to Local Racial/Ethnic Composition and Need

Authors: Hannah L. F. Cooper, ScD, Brian H. Bossak, Barbara Tempalski, Samuel R. Friedman, Don C. Des Jarlais

Published in: Journal of Urban Health | Issue 6/2009

Login to get access

Abstract

Pharmacies that sell over-the-counter (OTC) syringes are a major source of sterile syringes for injection drug users in cities and states where such sales are legal. In these cities and states, however, black injectors are markedly less likely to acquire syringes from pharmacies than white injectors. The present analysis documents spatial and temporal trends in OTC pharmacy access in New York City health districts over time (2001–2006) and investigates whether these trends are related to district racial/ethnic composition and to local need for OTC pharmacies. For each year of the study period, we used kernel density estimation methods to characterize spatial access to OTC pharmacies within each health district. Higher values on this measure indicate better access to these pharmacies. “Need” was operationalized using two different measures: the number of newly diagnosed injection-related AIDS cases per 10,000 residents (averaged across 1999–2001), and the number of drug-related hospital discharges per 10,000 residents (averaged across 1999–2001). District sociodemographic characteristics were assessed using 2000 US decennial census data. We used hierarchical linear models (HLM) for descriptive and inferential analyses and investigated whether the relationship between need and temporal trajectories in the Expanded Syringe Access Demonstration Program access varied by district racial/ethnic composition, controlling for district poverty rates. HLM analyses indicate that the mean spatial access to OTC pharmacies across New York City health districts was 12.71 in 2001 and increased linearly by 1.32 units annually thereafter. Temporal trajectories in spatial access to OTC pharmacies depended on both need and racial/ethnic composition. Within high-need districts, OTC pharmacy access was twice as high in 2001 and increased three times faster annually, in districts with higher proportions of non-Hispanic white residents than in districts with low proportions of these residents. In low-need districts, “whiter” districts had substantially greater baseline access to OTC pharmacies than districts with low proportions of non-Hispanic white residents. Access remained stable thereafter in low-need districts, regardless of racial/ethnic composition. Conclusions were consistent across both measures of “need” and persisted after controlling for local poverty rates. In both high- and low-need districts, spatial access to OTC pharmacies was greater in “Whiter” districts in 2001; in high-need districts, access also increased more rapidly over time in “whiter” districts. Ensuring equitable spatial access to OTC pharmacies may reduce injection-related HIV transmission overall and reduce racial/ethnic disparities in HIV incidence among injectors.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kottiri B, Friedman SR, Neaigus A, Curtis R, Des Jarlais DC. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2002; 30: 95-104.CrossRefPubMed Kottiri B, Friedman SR, Neaigus A, Curtis R, Des Jarlais DC. Risk networks and racial/ethnic differences in the prevalence of HIV infection among injection drug users. J Acquir Immune Defic Syndr. 2002; 30: 95-104.CrossRefPubMed
2.
go back to reference Kral A, Bluthenthal RN, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health. 1998; 88: 108-13.CrossRefPubMed Kral A, Bluthenthal RN, Watters JK. HIV seroprevalence among street-recruited injection drug and crack cocaine users in 16 US municipalities. Am J Public Health. 1998; 88: 108-13.CrossRefPubMed
3.
go back to reference Schoenbaum E, Hartel D, Selwyn P. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989; 321: 874-9.PubMed Schoenbaum E, Hartel D, Selwyn P. Risk factors for human immunodeficiency virus infection in intravenous drug users. N Engl J Med. 1989; 321: 874-9.PubMed
4.
go back to reference Watters JK, Estilo M, Kral A, Lorvick JJ. HIV infection among female injection-drug users recruited in community settings. Sex Transm Dis. 1994; 21: 321-8.PubMed Watters JK, Estilo M, Kral A, Lorvick JJ. HIV infection among female injection-drug users recruited in community settings. Sex Transm Dis. 1994; 21: 321-8.PubMed
6.
go back to reference Des Jarlais DC, McKnight C, Friedmann P. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000–2001. J Am Pharm Assoc. 2002; 42: S73-S6.CrossRef Des Jarlais DC, McKnight C, Friedmann P. Legal syringe purchases by injection drug users, Brooklyn and Queens, New York City, 2000–2001. J Am Pharm Assoc. 2002; 42: S73-S6.CrossRef
7.
go back to reference Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs L, Kassler WJ. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992–1993. J Acquir Immune Defic Syndr. 1995; 10: 82-9. Groseclose SL, Weinstein B, Jones TS, Valleroy LA, Fehrs L, Kassler WJ. Impact of increased legal access to needles and syringes on practices of injecting-drug users and police officers—Connecticut, 1992–1993. J Acquir Immune Defic Syndr. 1995; 10: 82-9.
8.
go back to reference Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales—Connecticut, 1992–1993. J Acquir Immune Defic Syndr. 1995; 10: 73-81. Valleroy LA, Weinstein B, Jones TS, Groseclose SL, Rolfs RT, Kassler WJ. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales—Connecticut, 1992–1993. J Acquir Immune Defic Syndr. 1995; 10: 73-81.
9.
go back to reference Deren S, Cleland CM, Fuller C, Kang S-Y, Des Jarlais DC, Vlahov D. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings. AIDS Behav. 2006; 10: 717-21.CrossRefPubMed Deren S, Cleland CM, Fuller C, Kang S-Y, Des Jarlais DC, Vlahov D. The impact of syringe deregulation on sources of syringes for injection drug users: preliminary findings. AIDS Behav. 2006; 10: 717-21.CrossRefPubMed
10.
go back to reference Cotten-Oldenburg N, Carr P, DeBoer J, Collison E, Novotny G. Impact of pharmacy-based syringe access on injection practices among injection drug users in Minnesota, 1998–1999. J Acquir Immune Defic Syndr. 2001; 27: 183-92.PubMed Cotten-Oldenburg N, Carr P, DeBoer J, Collison E, Novotny G. Impact of pharmacy-based syringe access on injection practices among injection drug users in Minnesota, 1998–1999. J Acquir Immune Defic Syndr. 2001; 27: 183-92.PubMed
11.
go back to reference Singer M, Baer H, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Reports. 1998; 113: 81-9.PubMed Singer M, Baer H, Scott G, Horowitz S, Weinstein B. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut. Public Health Reports. 1998; 113: 81-9.PubMed
12.
go back to reference Fuller C, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug users syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc. 2002; 42: S77-S82.CrossRef Fuller C, Ahern J, Vadnai L, et al. Impact of increased syringe access: preliminary findings on injection drug users syringe source, disposal, and pharmacy sales in Harlem, New York. J Am Pharm Assoc. 2002; 42: S77-S82.CrossRef
13.
go back to reference Fisher DG, Fenaughty AM, Cagle HH, Reynolds GL. Injection drug users' use of pharmacies for purchasing needles in Anchorage, Alaska. Int J Drug Policy. 2003; 14: 381-7.CrossRef Fisher DG, Fenaughty AM, Cagle HH, Reynolds GL. Injection drug users' use of pharmacies for purchasing needles in Anchorage, Alaska. Int J Drug Policy. 2003; 14: 381-7.CrossRef
14.
go back to reference Deren S, Fuller C, Pouget ER, et al. Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. Int J Drug Policy. 2003; 14: 373-9.CrossRef Deren S, Fuller C, Pouget ER, et al. Impact of expanding syringe access in New York on sources of syringes for injection drug users in Harlem and the Bronx, NYC, USA. Int J Drug Policy. 2003; 14: 373-9.CrossRef
15.
go back to reference Fuller C, Galea S, Blaney S, et al. Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethn Dis. 2004; 14: 589-96.PubMed Fuller C, Galea S, Blaney S, et al. Explaining the relationship between race/ethnicity and pharmacy purchased syringes among injection drug users in New York City. Ethn Dis. 2004; 14: 589-96.PubMed
16.
go back to reference Singer M, Himmelgreen D, Weeks M, Radda K, Martinez R. Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CT. Med Anthropol. 1997; 18: 107-30.PubMedCrossRef Singer M, Himmelgreen D, Weeks M, Radda K, Martinez R. Changing the environment of AIDS risk: findings on syringe exchange and pharmacy sales of syringes in Hartford, CT. Med Anthropol. 1997; 18: 107-30.PubMedCrossRef
17.
go back to reference Gostin L. The interconnected epidemics of drug dependency and AIDS. Harvard Civil Rights—Civil Liberties Law Review 1991; 26: 113–184. Gostin L. The interconnected epidemics of drug dependency and AIDS. Harvard Civil Rights—Civil Liberties Law Review 1991; 26: 113–184.
18.
go back to reference Friedman SR, Perlis T, Des Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health. 2001; 91: 791-3.CrossRefPubMed Friedman SR, Perlis T, Des Jarlais DC. Laws prohibiting over-the-counter syringe sales to injection drug users: relations to population density, HIV prevalence, and HIV incidence. Am J Public Health. 2001; 91: 791-3.CrossRefPubMed
19.
go back to reference Des Jarlais DC, Hagan H, Friedman SR. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1996; 274: 1226-31.CrossRef Des Jarlais DC, Hagan H, Friedman SR. Maintaining low HIV seroprevalence in populations of injecting drug users. JAMA. 1996; 274: 1226-31.CrossRef
20.
go back to reference Romeis JBG, Northup T, Hager-Mace L, Friedman C, Des Jarlais DC. The Relationship between State Statutory Restrictions on Access to Syringes and AIDS Rates among Injecting Drug Users: Final Report. Jefferson City, Missouri: Missouri Department of Health, Bureau of AIDS Prevention; 1994. Romeis JBG, Northup T, Hager-Mace L, Friedman C, Des Jarlais DC. The Relationship between State Statutory Restrictions on Access to Syringes and AIDS Rates among Injecting Drug Users: Final Report. Jefferson City, Missouri: Missouri Department of Health, Bureau of AIDS Prevention; 1994.
21.
go back to reference Lurie P, Reingold A. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. San Francisco: School of Public Health at the University of California, Berkeley; 1993. Lurie P, Reingold A. The Public Health Impact of Needle Exchange Programs in the United States and Abroad. San Francisco: School of Public Health at the University of California, Berkeley; 1993.
22.
go back to reference Burris S, Ng M. Deregulation of hypodermic needles and syringes as a public health measure: a report on emerging policy and law in the United States. George Mason University Civil Rights Law Journal. 2001; 12: 69–122. Burris S, Ng M. Deregulation of hypodermic needles and syringes as a public health measure: a report on emerging policy and law in the United States. George Mason University Civil Rights Law Journal. 2001; 12: 69–122.
23.
go back to reference Pouget ER, Deren S, Fuller C, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005; 39: 471-7.CrossRefPubMed Pouget ER, Deren S, Fuller C, et al. Receptive syringe sharing among injection drug users in Harlem and the Bronx during the New York State Expanded Syringe Access Demonstration Program. J Acquir Immune Defic Syndr. 2005; 39: 471-7.CrossRefPubMed
24.
go back to reference Espinozw P, Bouchard I, Ballian F, Polo DeVoto J. Has the open sale of syringes modified the syringe exchange habit of drug addicts? Abstract presented at: 4th International Conference on AIDS. Stockholm; 1988. Espinozw P, Bouchard I, Ballian F, Polo DeVoto J. Has the open sale of syringes modified the syringe exchange habit of drug addicts? Abstract presented at: 4th International Conference on AIDS. Stockholm; 1988.
25.
go back to reference Goldberg D, Watson HFS, Miller M, Gryer L, Follett E. Pharmacy supply of needles and syringes—the effect on spread of HIVamong intravenous drug misusers. Abstract presented at: 4th International Conference on AIDS. Stockholm; 1988. Goldberg D, Watson HFS, Miller M, Gryer L, Follett E. Pharmacy supply of needles and syringes—the effect on spread of HIVamong intravenous drug misusers. Abstract presented at: 4th International Conference on AIDS. Stockholm; 1988.
26.
go back to reference Ingold F, Ingold S. The effects of the liberalization of syringe sales on the behavior of intravenous drug users in France. Bull Narc. 1989; 41: 67-81.PubMed Ingold F, Ingold S. The effects of the liberalization of syringe sales on the behavior of intravenous drug users in France. Bull Narc. 1989; 41: 67-81.PubMed
27.
go back to reference Koester SK, Bush TW, Lewis BA. Limited access to syringes for injection drug users in pharmacies in Denver, Colorado. J Am Pharm Assoc. 2002; 42: S88-S91.CrossRef Koester SK, Bush TW, Lewis BA. Limited access to syringes for injection drug users in pharmacies in Denver, Colorado. J Am Pharm Assoc. 2002; 42: S88-S91.CrossRef
28.
go back to reference Finkelstein R, Tiger R, Greenwald R, Mukherjee R. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001–2002). J Am Pharm Assoc. 2002; 42: S83-S7.CrossRef Finkelstein R, Tiger R, Greenwald R, Mukherjee R. Pharmacy syringe sale practices during the first year of expanded syringe availability in New York City (2001–2002). J Am Pharm Assoc. 2002; 42: S83-S7.CrossRef
29.
go back to reference Compton W, Cottler L, Decker S, Mager D, Stringfellow R. Legal needle buying in St. Louis. Am J Public Health. 1992; 82: 595-6.CrossRefPubMed Compton W, Cottler L, Decker S, Mager D, Stringfellow R. Legal needle buying in St. Louis. Am J Public Health. 1992; 82: 595-6.CrossRefPubMed
30.
go back to reference Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2004; 61: 1026–44. Rhodes T, Singer M, Bourgois P, Friedman SR, Strathdee SA. The social structural production of HIV risk among injecting drug users. Soc Sci Med. 2004; 61: 1026–44.
31.
go back to reference Bruneau J, Daniel M, Kestens Y, Zang G, Genereux M. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programs. J Epidemiol Community Health. 2008; 62: 804-10.CrossRefPubMed Bruneau J, Daniel M, Kestens Y, Zang G, Genereux M. Associations between HIV-related injection behaviour and distance to and patterns of utilisation of syringe-supply programs. J Epidemiol Community Health. 2008; 62: 804-10.CrossRefPubMed
32.
go back to reference Rockwell R, Des Jarlais DC, Friedman SR, Perlis T, Paone D. Geographic proximity, policy, and utilization of syringe exchange programmes. AIDS Care. 1999; 11: 437-42.CrossRefPubMed Rockwell R, Des Jarlais DC, Friedman SR, Perlis T, Paone D. Geographic proximity, policy, and utilization of syringe exchange programmes. AIDS Care. 1999; 11: 437-42.CrossRefPubMed
33.
go back to reference Beardsley K, Wish E, Fitzelle D, O'Grady K, Arria A. Distance traveled to outpatient drug treatment and client retention. J Subst Abuse Treat. 2003; 25: 279-85.CrossRefPubMed Beardsley K, Wish E, Fitzelle D, O'Grady K, Arria A. Distance traveled to outpatient drug treatment and client retention. J Subst Abuse Treat. 2003; 25: 279-85.CrossRefPubMed
34.
go back to reference Fortney J, Booth B, Blow F, Bunn J. The effects of travel barriers and age on the utilization of alcoholism treatment aftercare. Am J Drug Alcohol Abuse. 1995; 21: 391-406.CrossRefPubMed Fortney J, Booth B, Blow F, Bunn J. The effects of travel barriers and age on the utilization of alcoholism treatment aftercare. Am J Drug Alcohol Abuse. 1995; 21: 391-406.CrossRefPubMed
35.
go back to reference Hutchinson S, Taylor A, Goldberg D, Gruer L. Factors associated with injecting risk behavior among serial community-wide samples of injecting drug users in Glasgow 1990–1994: implications for control and prevention of blood-bourne viruses. Addiction. 2000; 95: 931-40.CrossRefPubMed Hutchinson S, Taylor A, Goldberg D, Gruer L. Factors associated with injecting risk behavior among serial community-wide samples of injecting drug users in Glasgow 1990–1994: implications for control and prevention of blood-bourne viruses. Addiction. 2000; 95: 931-40.CrossRefPubMed
36.
go back to reference Bonilla-Silva E. White Supremacy and Racism in the Post-Civil Rights Era. Boulder: Rienner; 2001. Bonilla-Silva E. White Supremacy and Racism in the Post-Civil Rights Era. Boulder: Rienner; 2001.
37.
go back to reference Bluthenthal RN, Lorvick J, Kral AH, Erringer EA, Kahn JG. Collateral damage in the war on drugs: injection drug use. Int J Drug Policy. 1999; 10: 25-38.CrossRef Bluthenthal RN, Lorvick J, Kral AH, Erringer EA, Kahn JG. Collateral damage in the war on drugs: injection drug use. Int J Drug Policy. 1999; 10: 25-38.CrossRef
38.
go back to reference Cooper H, Moore L, Gruskin S, Krieger N. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: a qualitative study. Soc Sci Med. 2005; 61: 673-84.CrossRefPubMed Cooper H, Moore L, Gruskin S, Krieger N. The impact of a police drug crackdown on drug injectors' ability to practice harm reduction: a qualitative study. Soc Sci Med. 2005; 61: 673-84.CrossRefPubMed
39.
go back to reference Davis CS, Burris S, Kraut-Becher J, Lynch KG, Metzger D. Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. Am J Public Health. 2005; 95: 233-6.CrossRefPubMed Davis CS, Burris S, Kraut-Becher J, Lynch KG, Metzger D. Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. Am J Public Health. 2005; 95: 233-6.CrossRefPubMed
40.
go back to reference Friedman SR, Cooper HLF, Tempalski B, et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS. 2006; 20: 93-9.CrossRefPubMed Friedman SR, Cooper HLF, Tempalski B, et al. Relationships of deterrence and law enforcement to drug-related harms among drug injectors in US metropolitan areas. AIDS. 2006; 20: 93-9.CrossRefPubMed
41.
go back to reference Grund JP, Heckathorn D, Anthony D. In Eastern Connecticut, IDUs purchase syringes from pharmacies but don't carry syringes. JAIDS. 1995; 10: 105. Grund JP, Heckathorn D, Anthony D. In Eastern Connecticut, IDUs purchase syringes from pharmacies but don't carry syringes. JAIDS. 1995; 10: 105.
42.
go back to reference Koester SK. Copping, running, and paraphernalia laws: contextual variables and needle risk behavior among injection drug users in Denver. Human Organ. 1994; 53: 287-95. Koester SK. Copping, running, and paraphernalia laws: contextual variables and needle risk behavior among injection drug users in Denver. Human Organ. 1994; 53: 287-95.
43.
go back to reference Maher L, Dixon D. Policing and public health: law enforcement and harm reduction in a street-level drug market. Br J Criminol. 1999; 39: 488-512.CrossRef Maher L, Dixon D. Policing and public health: law enforcement and harm reduction in a street-level drug market. Br J Criminol. 1999; 39: 488-512.CrossRef
44.
go back to reference Philbin M, Pollini R, Ramos R, et al. Shooting gallery attendance among IDUs in Tijuana and Ciudad Juarez, Mexico: correlates, prevention opportunities, and the role of the environment. AIDS Behav. 2008; 12: 552-60.CrossRefPubMed Philbin M, Pollini R, Ramos R, et al. Shooting gallery attendance among IDUs in Tijuana and Ciudad Juarez, Mexico: correlates, prevention opportunities, and the role of the environment. AIDS Behav. 2008; 12: 552-60.CrossRefPubMed
45.
go back to reference Rhodes T, Mikhailova L, Sarang A, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med. 2003; 57: 39-54.CrossRefPubMed Rhodes T, Mikhailova L, Sarang A, et al. Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment. Soc Sci Med. 2003; 57: 39-54.CrossRefPubMed
46.
go back to reference Small W, Kerr T, Charette J, Schechter M, Spittal P. Impacts of intensified police activity on injection drug users: evidence from an ethnographic investigation. Int J Drug Policy. 2006; 17: 85-95.CrossRef Small W, Kerr T, Charette J, Schechter M, Spittal P. Impacts of intensified police activity on injection drug users: evidence from an ethnographic investigation. Int J Drug Policy. 2006; 17: 85-95.CrossRef
47.
go back to reference Wood E, Kerr T, Small W, Jones J, Schechter M, Tyndall M. The impact of police presence on access to needle exchange programs. JAIDS. 2003; 34: 116-8.PubMed Wood E, Kerr T, Small W, Jones J, Schechter M, Tyndall M. The impact of police presence on access to needle exchange programs. JAIDS. 2003; 34: 116-8.PubMed
48.
go back to reference Friedman SR, Cooper H, Osbourne A. Structural and social contexts of HIV risk among African-Americans. Am J Public Health. 2009; 99: 1002-8. Friedman SR, Cooper H, Osbourne A. Structural and social contexts of HIV risk among African-Americans. Am J Public Health. 2009; 99: 1002-8.
49.
go back to reference Beckett K, Nyrop K, Pfingst L. Race, drugs, and policing: understanding disparities in drug delivery arrests. Criminology. 2006; 44: 105-37.CrossRef Beckett K, Nyrop K, Pfingst L. Race, drugs, and policing: understanding disparities in drug delivery arrests. Criminology. 2006; 44: 105-37.CrossRef
50.
go back to reference Cooper HLF, Wypij D, Krieger N. Police drug crackdowns and hospitalisation rates for illicit-injection-related infections in New York City. Int J Drug Policy. 2005; 16: 150-60.CrossRef Cooper HLF, Wypij D, Krieger N. Police drug crackdowns and hospitalisation rates for illicit-injection-related infections in New York City. Int J Drug Policy. 2005; 16: 150-60.CrossRef
51.
go back to reference Spernak SM, Mintz M, Paulson J, et al. Neighborhood racial composition and availability of asthma drugs in retail pharmacies. J Asthma. 2005; 42: 731-5.CrossRefPubMed Spernak SM, Mintz M, Paulson J, et al. Neighborhood racial composition and availability of asthma drugs in retail pharmacies. J Asthma. 2005; 42: 731-5.CrossRefPubMed
52.
go back to reference Morrison RS, Wallenstein S, Natale D, Senzel RS, Huang L-L. “We don't carry that”—failure of pharmacies in predominatly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med. 2000; 342: 1023-6.CrossRefPubMed Morrison RS, Wallenstein S, Natale D, Senzel RS, Huang L-L. “We don't carry that”—failure of pharmacies in predominatly nonwhite neighborhoods to stock opioid analgesics. N Engl J Med. 2000; 342: 1023-6.CrossRefPubMed
53.
go back to reference Pearson S-A, Soumerai S, Mah C, et al. Racial disparities in access after regulatory surveillance of benzodiazepines. Arch Inter Med. 2006; 166: 572-9.CrossRef Pearson S-A, Soumerai S, Mah C, et al. Racial disparities in access after regulatory surveillance of benzodiazepines. Arch Inter Med. 2006; 166: 572-9.CrossRef
55.
go back to reference The New York State AIDS Advisory Council. Report on Syringe Access in New York State. New York: NYSDOH; 2005. The New York State AIDS Advisory Council. Report on Syringe Access in New York State. New York: NYSDOH; 2005.
56.
go back to reference United Hospital Fund. UHF Health Atlas. New York City: United Hospital Fund; 2005. United Hospital Fund. UHF Health Atlas. New York City: United Hospital Fund; 2005.
57.
go back to reference New York City Department of Health and Mental Hygiene. City Wide Community Health Profile. New York: NYCDOH; 2001. New York City Department of Health and Mental Hygiene. City Wide Community Health Profile. New York: NYCDOH; 2001.
59.
go back to reference Guargliardo M, Ronzio C, Cheung I, Chacko E, Joseph J. Physcian accessibility: an urban case study of pediatric providers. Health and Place. 2004; 10: 273–83. Guargliardo M, Ronzio C, Cheung I, Chacko E, Joseph J. Physcian accessibility: an urban case study of pediatric providers. Health and Place. 2004; 10: 273–83.
60.
go back to reference Luo W. Using a GIS-based floating catchment method to assess areas with shortage of physicians. Health Place. 2004; 10: 1-11.CrossRefPubMed Luo W. Using a GIS-based floating catchment method to assess areas with shortage of physicians. Health Place. 2004; 10: 1-11.CrossRefPubMed
61.
go back to reference Luo W, Wang F. Measures of spatial accessibility of health care in a GIS environment: synthesis and a case study in the Chicago region. Environ Plann B Plann Des. 2003; 30: 865-84.CrossRef Luo W, Wang F. Measures of spatial accessibility of health care in a GIS environment: synthesis and a case study in the Chicago region. Environ Plann B Plann Des. 2003; 30: 865-84.CrossRef
62.
go back to reference Takahashi L. Homelessness, AIDS, and stigmatization. Oxford: Clarendon; 1998. Takahashi L. Homelessness, AIDS, and stigmatization. Oxford: Clarendon; 1998.
63.
go back to reference Tempalski B, Friedman R, Keem M, Cooper H, Friedman SR. NIMBY localism and national inequitable exclusion alliances: the case of syringe exchange programs in the United States. Geoforum. 2007; 38: 1250-63.CrossRefPubMed Tempalski B, Friedman R, Keem M, Cooper H, Friedman SR. NIMBY localism and national inequitable exclusion alliances: the case of syringe exchange programs in the United States. Geoforum. 2007; 38: 1250-63.CrossRefPubMed
64.
go back to reference Khan A. An integrated approach to measuring potential spatial access to health care services. Socioecon Plann Sci. 1992; 26: 275-87.CrossRefPubMed Khan A. An integrated approach to measuring potential spatial access to health care services. Socioecon Plann Sci. 1992; 26: 275-87.CrossRefPubMed
65.
go back to reference Joseph A, Phillips D. Accessibility and Utilization: Geographical Perspectives on Health Care Delivery. New York: Harper and Row; 1984. Joseph A, Phillips D. Accessibility and Utilization: Geographical Perspectives on Health Care Delivery. New York: Harper and Row; 1984.
66.
go back to reference Phillips D. Health and Health Care in the Third World. Essex: Longman Scientific and Technical; 1990. Phillips D. Health and Health Care in the Third World. Essex: Longman Scientific and Technical; 1990.
67.
go back to reference Thouez J, Bodson P, Joseph A. Some methods for measuring the geographic accessibility of medical service in rural regions. Med Care. 1988; 26: 34-44.CrossRefPubMed Thouez J, Bodson P, Joseph A. Some methods for measuring the geographic accessibility of medical service in rural regions. Med Care. 1988; 26: 34-44.CrossRefPubMed
68.
go back to reference Bailey T, Gastrell A. Interactive Spatial Data Analysis. Essex: Longman Scientific and Technical; 1995. Bailey T, Gastrell A. Interactive Spatial Data Analysis. Essex: Longman Scientific and Technical; 1995.
69.
go back to reference Cromley E, McClafferty S. GIS and Public Health. New York: Guilford; 2002. Cromley E, McClafferty S. GIS and Public Health. New York: Guilford; 2002.
70.
go back to reference Lawson A. Statistical Methods in Spatial Epidemiology. New York: Wiley; 2001. Lawson A. Statistical Methods in Spatial Epidemiology. New York: Wiley; 2001.
71.
go back to reference Krieger N, Waterman P, Lemieux K, Zierler S, Hogan J. On the wrong side of the tracts? Evaluating the accuracy of geocoding in public health research. Am J Public Health. 2001; 91: 1114-6.CrossRefPubMed Krieger N, Waterman P, Lemieux K, Zierler S, Hogan J. On the wrong side of the tracts? Evaluating the accuracy of geocoding in public health research. Am J Public Health. 2001; 91: 1114-6.CrossRefPubMed
72.
go back to reference McClafferty S, Grady S. Prenatal care need and access: a GIS analysis. J Med Syst. 2004; 28: 321-33.CrossRef McClafferty S, Grady S. Prenatal care need and access: a GIS analysis. J Med Syst. 2004; 28: 321-33.CrossRef
73.
go back to reference McClafferty S, Grady S. Immigration and geographic access to prenatal clinics in Brooklyn, NY: a geographic information systems analysis. Am J Public Health. 2005; 95: 638-40.CrossRef McClafferty S, Grady S. Immigration and geographic access to prenatal clinics in Brooklyn, NY: a geographic information systems analysis. Am J Public Health. 2005; 95: 638-40.CrossRef
74.
go back to reference Wang F. Quantitative Methods in Applications in GIS. New York: Taylor and Francis; 2006. Wang F. Quantitative Methods in Applications in GIS. New York: Taylor and Francis; 2006.
76.
go back to reference Hartwig F, Dearing B. Exploratory Data Analysis. Newbury Park: Sage; 1979. Hartwig F, Dearing B. Exploratory Data Analysis. Newbury Park: Sage; 1979.
77.
go back to reference Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press; 2003. Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York: Oxford University Press; 2003.
78.
go back to reference Bauer DJ, Curran PJ. Probing interactions in fixed and multilevel regression: inferential and graphical techniques. Multivariate Behav Res. 2005; 40: 373-400.CrossRef Bauer DJ, Curran PJ. Probing interactions in fixed and multilevel regression: inferential and graphical techniques. Multivariate Behav Res. 2005; 40: 373-400.CrossRef
79.
go back to reference Preacher C, Curran PJ, Bauer DJ. Computational tools for probing interaction effects in multiple linear regression, multilevel modeling, and latent curve analysis. J Educ Behav Stat. 2006; 31: 437-48.CrossRef Preacher C, Curran PJ, Bauer DJ. Computational tools for probing interaction effects in multiple linear regression, multilevel modeling, and latent curve analysis. J Educ Behav Stat. 2006; 31: 437-48.CrossRef
80.
go back to reference Jaccard J, Turrisi R. Interaction Effects in Multiple Regression. 2nd ed. Thousand Oaks: Sage; 2003. Jaccard J, Turrisi R. Interaction Effects in Multiple Regression. 2nd ed. Thousand Oaks: Sage; 2003.
81.
go back to reference ESRI. ArcInfo software program version 9.2. In; 2006. ESRI. ArcInfo software program version 9.2. In; 2006.
82.
go back to reference SAS Institute I. SAS/STAT 9.2. In. Cary, NC: SAS Institute; 2008. SAS Institute I. SAS/STAT 9.2. In. Cary, NC: SAS Institute; 2008.
83.
go back to reference New York City Department of Health and Mental Hygiene. Community Health Profiles: Stapleton and St. George. New York City: NYCDOHMH; 2006. New York City Department of Health and Mental Hygiene. Community Health Profiles: Stapleton and St. George. New York City: NYCDOHMH; 2006.
84.
go back to reference Tempalski B, Flom PL, Friedman SR, et al. Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas. Am J Public Health. 2007; 97: 437-47.CrossRefPubMed Tempalski B, Flom PL, Friedman SR, et al. Social and political factors predicting the presence of syringe exchange programs in 96 US metropolitan areas. Am J Public Health. 2007; 97: 437-47.CrossRefPubMed
85.
go back to reference Friedman SR, Tempalski B, Brady JE, et al. Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America. Int J Drug Policy. 2007; 18: 475-85.CrossRefPubMed Friedman SR, Tempalski B, Brady JE, et al. Predictors of the degree of drug treatment coverage for injection drug users in 94 metropolitan areas in the United States of America. Int J Drug Policy. 2007; 18: 475-85.CrossRefPubMed
86.
go back to reference Bluthenthal RN, Kral AH, Lorvick J, Watters JK. Impact of law enforcement on syringe exchange prorgams: a look at Oakland and San Francisco. Med Anthropol. 1997; 18: 61-83.PubMedCrossRef Bluthenthal RN, Kral AH, Lorvick J, Watters JK. Impact of law enforcement on syringe exchange prorgams: a look at Oakland and San Francisco. Med Anthropol. 1997; 18: 61-83.PubMedCrossRef
87.
go back to reference Rich J, Strong L, Towe C, McKenzie M. Obstacles to needle exchange participation in Rhode Island. J Acquir Immune Defic Syndr. 1999; 21: 396-400.CrossRefPubMed Rich J, Strong L, Towe C, McKenzie M. Obstacles to needle exchange participation in Rhode Island. J Acquir Immune Defic Syndr. 1999; 21: 396-400.CrossRefPubMed
89.
go back to reference Fuller C, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97: 117-24.CrossRefPubMed Fuller C, Galea S, Caceres W, Blaney S, Sisco S, Vlahov D. Multilevel community-based intervention to increase access to sterile syringes among injection drug users through pharmacy sales in New York City. Am J Public Health. 2007; 97: 117-24.CrossRefPubMed
90.
go back to reference Reich W, Compton W, Horton JC, et al. Injection Drug Users Report Good Access to Pharmacy Sale of Syringes. J Am Pharm Assoc. 2002; 42: S68-S72.CrossRef Reich W, Compton W, Horton JC, et al. Injection Drug Users Report Good Access to Pharmacy Sale of Syringes. J Am Pharm Assoc. 2002; 42: S68-S72.CrossRef
Metadata
Title
Temporal Trends in Spatial Access to Pharmacies that Sell Over-the-Counter Syringes in New York City Health Districts: Relationship to Local Racial/Ethnic Composition and Need
Authors
Hannah L. F. Cooper, ScD
Brian H. Bossak
Barbara Tempalski
Samuel R. Friedman
Don C. Des Jarlais
Publication date
01-11-2009
Publisher
Springer US
Published in
Journal of Urban Health / Issue 6/2009
Print ISSN: 1099-3460
Electronic ISSN: 1468-2869
DOI
https://doi.org/10.1007/s11524-009-9399-7

Other articles of this Issue 6/2009

Journal of Urban Health 6/2009 Go to the issue